• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[东约特兰四所医院的抗凝治疗——使用共享计算机程序进行质量控制]

[Anticoagulant therapy at four hospitals in Ostergötland--quality control using a shared computer program].

作者信息

Karlander Sven, Lindahl Tomas L

机构信息

Invärtesmedicinska kliniken, Universitetssjukhuset MAS, Malmö.

出版信息

Lakartidningen. 2002 Mar 19;99(14):1592-4, 1597-8.

PMID:12025215
Abstract

Anticoagulation therapy in four hospital anticoagulation clinics in the Swedish county of Ostergötland was evaluated using statistical functions in a software package for patient management used by all four clinics. During the period 1998-2000 the degree of therapeutic control of anticoagulation differed between the four hospitals. However the overall quality of therapeutic control tended to be better than that reported from routine treatment at other centers and comparable to that found in randomized controlled trials of anticoagulation treatment of atrial fibrillation. The recorded frequency of complications was low but probably represents an underestimate, as there was no systematic follow-up of each patient at any of the hospitals. In the future, quality control of clinical follow-up of anticoagulation treatment must be improved. There is also a need for more user-friendly and flexible software packages.

摘要

利用瑞典东约特兰郡四家医院抗凝门诊均使用的一款患者管理软件包中的统计功能,对这四家医院的抗凝治疗进行了评估。在1998年至2000年期间,四家医院的抗凝治疗控制程度存在差异。然而,治疗控制的总体质量往往优于其他中心常规治疗报告的质量,且与心房颤动抗凝治疗随机对照试验中的质量相当。记录的并发症发生率较低,但可能存在低估,因为四家医院均未对每位患者进行系统随访。未来,必须改进抗凝治疗临床随访的质量控制。还需要更用户友好、更灵活的软件包。

相似文献

1
[Anticoagulant therapy at four hospitals in Ostergötland--quality control using a shared computer program].[东约特兰四所医院的抗凝治疗——使用共享计算机程序进行质量控制]
Lakartidningen. 2002 Mar 19;99(14):1592-4, 1597-8.
2
Management of oral anticoagulant therapy in the real practice of an anticoagulation clinic: focus on atrial fibrillation.
Blood Coagul Fibrinolysis. 2005 Oct;16(7):491-4.
3
Therapeutic anticoagulation in the trauma patient: is it safe?创伤患者的治疗性抗凝:安全吗?
Surgery. 2008 Oct;144(4):591-6; discussion 596-7. doi: 10.1016/j.surg.2008.06.022. Epub 2008 Aug 29.
4
[A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].[心血管疾病患者口服抗凝治疗实践的回顾性调查]
Orv Hetil. 2004 Aug 8;145(32):1643-7.
5
The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial.比利时口服抗凝治疗改善研究:一项随机临床试验。
Eur Heart J. 2005 Oct;26(20):2159-65. doi: 10.1093/eurheartj/ehi327. Epub 2005 May 25.
6
Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial.长期由药剂师管理的抗凝服务是否有效?一项实用的随机对照试验。
Am Heart J. 2008 Jul;156(1):148-54. doi: 10.1016/j.ahj.2008.02.009. Epub 2008 Jun 3.
7
[Questionnaires at anticoagulation clinics in the Southern health care region. A national quality registry is needed].[南部医疗保健地区抗凝门诊的调查问卷。需要一个全国性质量登记系统]
Lakartidningen. 2008;105(17-18):1284-8.
8
Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records.瑞典初级卫生保健中慢性房颤抗凝治疗的发生率及质量:一项基于电子病历的回顾性研究
BMC Clin Pharmacol. 2004 Feb 9;4:1. doi: 10.1186/1472-6904-4-1.
9
Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.机械心脏瓣膜置换术、心房颤动或心肌梗死患者预防动脉血栓形成的口服抗凝治疗最佳水平:4202例患者的前瞻性研究
Arch Intern Med. 2009 Jul 13;169(13):1203-9. doi: 10.1001/archinternmed.2009.176.
10
Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.基于人群的心房颤动抗栓治疗管理评估
Can J Cardiol. 2005 Mar;21(3):257-66.